Ionis Pharmaceuticals (IONS) Treasury Shares (2012 - 2025)
Ionis Pharmaceuticals (IONS) posted quarterly Treasury Shares of $4.7 million for Q4 2025, up 23.83% year-over-year from $3.8 million in Q4 2024, and up 23.83% quarter-over-quarter from $3.8 million in Q4 2024.
Ionis Pharmaceuticals (IONS) Treasury Shares (2012 - 2025) Analysis & Trends
Ionis Pharmaceuticals' Treasury Shares history runs 14 years deep, the most recent figure standing at $4.7 million for Q4 2025.
- In Q4 2025, Treasury Shares rose 23.83% year-over-year to $4.7 million; the TTM figure through Dec 2025 stood at $4.7 million (up 23.83% YoY), while the FY2025 annual figure was $4.7 million, up 23.83% from the prior year.
- Treasury Shares for Q4 2025 stood at $4.7 million, up from $3.8 million in the prior quarter.
- The five-year high for Treasury Shares was $4.7 million in Q4 2025, with the low at $2.6 million in Q4 2021.
- The 5-year median for Treasury Shares is $3.2 million (2023), against an average of $3.4 million.
- The sharpest annual moves came in 2022 and 2025: Treasury Shares gained 5.65% in 2022, then grew 23.83% in 2025.
- Ionis Pharmaceuticals' Treasury Shares stood at $2.6 million in 2021, then climbed by 5.65% to $2.8 million in 2022, then climbed by 17.1% to $3.2 million in 2023, then advanced by 18.28% to $3.8 million in 2024, then climbed by 23.83% to $4.7 million in 2025.
- Business Quant data shows IONS's Treasury Shares at $4.7 million in Q4 2025, $3.8 million in Q4 2024, and $3.2 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.74 Mn |
| Dec 31, 2025 | 4.74 Mn |
| Dec 31, 2024 | 3.83 Mn |
| Dec 31, 2024 | 3.83 Mn |
| Dec 31, 2023 | 3.24 Mn |
| Dec 31, 2023 | 3.24 Mn |
| Dec 31, 2022 | 2.77 Mn |
| Dec 31, 2022 | 2.77 Mn |
| Dec 31, 2021 | 2.62 Mn |
| Dec 31, 2021 | 2.62 Mn |
| Dec 31, 2020 | 2.37 Mn |
| Dec 31, 2020 | 2.37 Mn |
| Dec 31, 2019 | 1.87 Mn |
| Dec 31, 2019 | 1.87 Mn |
| Dec 31, 2018 | 1.25 Mn |
| Dec 31, 2018 | 1.25 Mn |
| Dec 31, 2017 | 863,000.00 |
| Dec 31, 2017 | 863,000.00 |
| Dec 31, 2016 | 778,000.00 |
| Dec 31, 2016 | 778,000.00 |